Tickers

1. Composite Trajectory Verdict

For a development-stage mining company with no mineral reserves yet, all three statements carry roughly equal weight: the income statement shows whether operating margins are emerging, the cash flow statement reveals the sustainability of development spending, and the balance sheet tracks the liquidity and leverage needed to fund the multi-year build-out.

Composite Trajectory: Mixed

Revenue and gross profit are improving markedly (FY2025 revenue +89% to $95.2M, gross profit $11.5M vs -$15.7M; H1 2026 revenue +83% to $76.7M, gross profit $24.7M vs $3.7M) (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, MD&A Discussion of Financial Results). However, GAAP net loss widened in both annual and interim periods (FY2025 -$198.8M vs -$121.5M; H1 2026 -$131.1M vs -$71.4M; Q2 2026 -$52.5M vs -$30.2M) (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, MD&A Discussion of Financial Results). Operating cash flow deteriorated in the first half of 2026 (-$94.7M vs -$34.0M) while annual operating cash flow was flat (-$83.6M vs -$82.5M) (10-Q 2026-06-30, MD&A Discussion of Financial Results; 10-K 2025-12-31, Consolidated Statements of Cash Flows). The balance sheet shows higher cash ($63.2M vs $19.0M at Dec-31) but a wider working capital deficit (-$37.9M vs -$31.7M) and a doubled current debt portion ($76.8M vs $37.8M) (10-K 2025-12-31, Consolidated Balance Sheets; 10-K 2025-12-31, MD&A Liquidity and Capital Resources).

2. Red Flags

• GAAP net loss vs. adjusted loss gap widened sharply: FY2025 adjusted loss -$122.9M vs GAAP -$198.8M (difference $75.9M) versus FY2024 difference $10.3M, driven by $26.2M PP&E write-down and $47.2M net fair-value losses on derivatives (10-K 2025-12-31, Non-GAAP Financial Performance Measures; 10-K 2025-12-31, Consolidated Statements of Operations).
• Operating cash flow deteriorated in H1 2026: -$94.7M vs -$34.0M in H1 2025, a 178% increase in cash burn (10-Q 2026-06-30, MD&A Discussion of Financial Results).
• Working capital deficit widened to -$37.9M at Dec-31 2025 from -$31.7M at Dec-31 2024 despite cash increase (10-K 2025-12-31, MD&A Liquidity and Capital Resources).
• Current portion of long-term debt more than doubled to $76.8M at Dec-31 2025 from $37.8M at Dec-31 2024, primarily due to Orion Convertible Loan reclassification (10-K 2025-12-31, Consolidated Balance Sheets).
• Auditor’s going-concern emphasis: “substantial doubt about the Company’s ability to continue as a going concern” due to working capital deficit and operating losses (10-K 2025-12-31, Report of Independent Registered Public Accounting Firm).
• Recurring “non-recurring” fair-value losses: derivative revaluation losses appeared in both FY2024 ($2.0M gain) and FY2025 ($47.2M loss) and again in H1 2026 ($48.9M loss) (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, MD&A Discussion of Financial Results).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Revenue grew 89% year-over-year to $95.2M in FY2025 and 83% to $76.7M in H1 2026, with average realized gold price rising 44% and 54% respectively (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, MD&A Discussion of Financial Results). Gross profit swung from -$15.7M to +$11.5M annually and from $3.7M to $24.7M in H1 (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, MD&A Discussion of Financial Results). However, pre-development, evaluation and exploration expenses nearly doubled to $66.1M in FY2025 and tripled to $55.0M in H1 2026 (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, MD&A Discussion of Financial Results). A $26.2M PP&E write-down and $47.2M net other expense (mainly derivative fair-value losses) pushed FY2025 loss from operations to -$124.4M from -$89.1M; H1 2026 loss from operations widened to -$56.0M from -$34.5M (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, MD&A Discussion of Financial Results). Net loss per share improved slightly annually (-$0.30 vs -$0.34) due to share count growth but worsened in H1 2026 (-$0.15 vs -$0.14) (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, MD&A Discussion of Financial Results).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Annual cash used in operating activities was nearly flat at -$83.6M in FY2025 vs -$82.5M in FY2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows). However, quarterly and six-month trends show sharp deterioration: Q2 2026 operating cash outflow -$49.6M vs -$11.3M in Q2 2025, and H1 2026 -$94.7M vs -$34.0M in H1 2025 (10-Q 2026-06-30, MD&A Discussion of Financial Results). Investing cash outflows increased to -$9.6M in FY2025 from -$1.6M in FY2024, reflecting Lone Tree Plant study and Granite Creek water treatment spending (10-K 2025-12-31, Consolidated Statements of Cash Flows). Financing inflows surged to $139.0M in FY2025 from $82.7M in FY2024, and the post-period recapitalization raised $637M net in Q1 2026, lifting cash and equivalents to $464.6M at June 30, 2026 (10-K 2025-12-31, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, MD&A Operational and Financial Highlights). The core operating cash generation trend is negative and accelerating.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Cash and equivalents rose to $63.2M at Dec-31 2025 from $19.0M a year earlier, and restricted cash grew to $42.0M from $40.3M (10-K 2025-12-31, Consolidated Balance Sheets). Inventory nearly doubled to $29.3M from $15.3M (10-K 2025-12-31, Note 3). PP&E net declined to $556.4M from $572.4M after a $26.2M write-down of Lone Tree Plant assets (10-K 2025-12-31, Note 5). Total liabilities increased to $356.6M from $315.0M, with the current portion of long-term debt jumping to $76.8M from $37.8M (Orion Convertible Loan maturity June 30, 2026) (10-K 2025-12-31, Consolidated Balance Sheets; 10-K 2025-12-31, Note 6). Equity rose slightly to $346.8M from $340.7M, but the accumulated deficit deepened to -$483.7M from -$284.8M (10-K 2025-12-31, Consolidated Statements of Changes in Equity). Working capital deficit widened to -$37.9M from -$31.7M (10-K 2025-12-31, MD&A Liquidity and Capital Resources). Subsequent to Dec-31, the Q1 2026 recapitalization added ~$400M cash and retired legacy debt, but the June 30, 2026 balance sheet details beyond cash are not provided in the filings.

6. Data Gaps

• Full balance sheet as of June 30, 2026 (only cash and equivalents disclosed in 10-Q 2026-06-30).
• Quarterly cash flow statements for Q1 2026 and standalone Q2 2026 (only six-month aggregates provided in 10-Q 2026-06-30).
• Detailed cost-of-sales breakdown by segment for quarterly periods (only annual segment data in 10-K 2025-12-31, Note 15).
• Mineral reserve estimates (all projects remain exploration-stage per S-K 1300, noted throughout filings).
• Feasibility study results for Granite Creek, Cove, and Archimedes (expected Q3 2026, Q3 2026, and mid-2027 respectively per 10-Q 2026-06-30 MD&A).
• Post-recapitalization debt maturity schedule and covenant compliance details (summarized in 10-Q 2026-06-30 MD&A but not tabulated).